Humira

Entyvio vs Humira (Vedolizumab Vs Adalimumab)

by
entyvio vs humira vedolizumab vs adalimumab

Entyvio vs Humira (Vedolizumab Vs Adalimumab) is a head to head comparison of the two tumor necrosis factor inhibitors (TNF inhibitors) in the treatment of patients with inflammatory bowel diseases. Entyvio is a humanized IgG1 monoclonal antibody that acts against α4β7 integrin which plays a main role in gastrointestinal inflammation. While Humira is a TNF … Read more

TNF Inhibitors – An Overview of Their Use in Immune-mediated Diseases

by
tnf inhibitors classification

TNF inhibitors are being increasingly used in the treatment of various immune-mediated diseases such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel diseases, and psoriasis. There are five tumor necrosis factor inhibitors available to treat rheumatoid arthritis and other immune-mediated diseases worldwide. Biosimilar versions of TNF inhibitors are now available in certain countries. Additional biosimilar agents … Read more